Jose Allas
Family Medicine · Lubbock, TXNPI 1669437455
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 129 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 26 manufacturers reported payments, led by AbbVie at 25.0% of the total. Reporting peaked in 2021 at $705 and has fallen 52.5% since, to $335 in 2022.
Across 129 payments — averaging $14.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$463
- GSK$252
- Novo Nordisk$176
- Lilly USA, LLC$111
- Amgen$99
- Takeda Pharmaceuticals U.S.A., Inc.$81
- plus $672 from 20 others
What the payments were for
- Food & beverage$1,854100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 33 | $463 |
| GSK | 21 | $252 |
| Novo Nordisk | 13 | $176 |
| Lilly USA, LLC | 7 | $111 |
| Amgen | 7 | $99 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $81 |
| Radius Health, Inc. | 5 | $65 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $64 |
| Esperion Therapeutics, Inc. | 4 | $64 |
| Nestle Healthcare Nutrition Inc. | 4 | $53 |
| Mylan Specialty L.p. | 3 | $44 |
| Supernus Pharmaceuticals, Inc. | 2 | $40 |
| Vivus LLC | 2 | $38 |
| Astellas Pharma US Inc | 2 | $38 |
| Nabriva Therapeutics, PLC | 2 | $36 |
| Johnson & Johnson | 2 | $34 |
| Novartis | 2 | $31 |
| Sanofi-aventis U.S. LLC | 2 | $31 |
| Eisai Inc. | 2 | $25 |
| Harmony Biosciences LLC | 1 | $20 |
| Xeris Pharmaceuticals, Inc. | 1 | $19 |
| Biogen | 1 | $19 |
| Pfizer | 1 | $15 |
| Philips North America LLC | 1 | $13 |
| Medicure Pharma Inc. | 1 | $13 |
| Merck | 1 | $11 |
How this compares
$1,854 in reported general payments places this provider in the 70th percentile of 8,760 family medicine providers in Texas.
Other family medicine in Lubbock
- Michael MendezLubbock$368K
- Carlos CamposNew Braunfels$1.5M
- Aaron KingSan Antonio$1.1M
- Bradley WassonArlington$734K
- Cynthia BrinsonAustin$402K
- Sang Tae KimAmarillo$368K
- Sumit PerakathuHarlingen$342K
- Joel SolisMcAllen$324K
- Robert CampbellFort Worth$318K
- Jose LedezmaEdinburg$300K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.